Related references
Note: Only part of the references are listed.
Review
Medicine, General & Internal
Xaquin Castro Dopico et al.
Summary: Adaptive immune responses are crucial for viral clearance and protection against re-infection, including SARS-CoV-2. The rapid characterization of the immune response to the virus during the first 20 months of the pandemic has provided a detailed understanding. The development and global rollout of effective COVID-19 vaccines have made a significant impact, although challenges remain in terms of equal access.
JOURNAL OF INTERNAL MEDICINE
(2022)
Article
Infectious Diseases
Oktavija Dakoviv Rode et al.
Summary: The study from Croatia highlighted the importance of combining diagnostic methods for COVID-19 diagnosis, as different serological tests showed varying sensitivity in detecting anti-SARS-CoV-2 antibodies. The antibody response in COVID-19 varies depending on the time of serum collection, disease severity, and type of test used.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
(2021)
Article
Multidisciplinary Sciences
Christian Gaebler et al.
Summary: After infection with SARS-CoV-2, antibody levels against the spike protein decrease significantly, but the number of memory B cells remain unchanged, indicating an evolving humoral response at 6.2 months after infection.
Article
Medicine, General & Internal
Sara Y. Tartof et al.
Summary: This study aimed to assess the overall and variant-specific effectiveness of the BNT162b2 vaccine against SARS-CoV-2 infections and COVID-19-related hospital admissions among members of a healthcare system in California. The effectiveness of the vaccine remained high against hospital admissions even up to 6 months after full vaccination, despite a decline in effectiveness against SARS-CoV-2 infections over time, which was likely due to waning immunity rather than the delta variant escaping vaccine protection.
Article
Medicine, General & Internal
Yair Goldberg et al.
Summary: The immunity against the delta variant of SARS-CoV-2 waned in all age groups in Israel a few months after receiving the second dose of the vaccine, leading to an increase in infection and severe cases.
NEW ENGLAND JOURNAL OF MEDICINE
(2021)
Article
Medicine, General & Internal
Einav G. Levin et al.
Summary: A study in Israel revealed that waning immunity after receiving two doses of the BNT162b2 vaccine led to an increase in the incidence of SARS-CoV-2 infection. Levels of spike-binding IgG and neutralizing antibodies decreased more significantly in men, individuals aged 65 or older, and immunosuppressed individuals in a longitudinal study involving nearly 4000 healthcare workers.
NEW ENGLAND JOURNAL OF MEDICINE
(2021)
Article
Medicine, General & Internal
Hiam Chemaitelly et al.
Summary: In a study conducted in Qatar involving over 900,000 participants, vaccine effectiveness peaked at 77.5% in the first month after the second dose. However, it declined afterwards to as low as 20% in months 5 through 7 after vaccination, while protection against severe Covid-19 remained above 90% for at least 6 months.
NEW ENGLAND JOURNAL OF MEDICINE
(2021)
Article
Virology
Andrea Giacomelli et al.
Summary: Analysis of COVID-19 patient cases showed that male patients are more likely to present critically ill upon hospital admission, while age, critical disease at hospital admission, and obesity are associated with higher odds of death.
JOURNAL OF MEDICAL VIROLOGY
(2021)
Letter
Medicine, General & Internal
Florian Krammer et al.
NEW ENGLAND JOURNAL OF MEDICINE
(2021)
Article
Infectious Diseases
Ilaria Vicenti et al.
Summary: Vaccination after infection can boost neutralizing antibody levels significantly higher than in uninfected individuals. Asymptomatic individuals with previous infection show a significant increase in neutralizing antibody titres after receiving the first vaccine dose.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
(2021)
Article
Infectious Diseases
Mitnala Sasikala et al.
Summary: After a single dose of mRNA vaccine, individuals previously infected with SARS-CoV-2 exhibited higher levels of immune memory compared to those with no prior exposure, including neutralizing antibody response and memory T and B cell counts.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
(2021)
Article
Microbiology
Madhusudhanan Narasimhan et al.
Summary: This study evaluated antibody responses in different populations after vaccination using new serological assays, demonstrating a significant increase in IgGSP and IgMSP values post vaccination.
JOURNAL OF CLINICAL MICROBIOLOGY
(2021)
Article
Immunology
Robert Flisiak et al.
Summary: The study found that individuals with a history of COVID-19 have higher levels of specific antibodies after vaccination, especially in anti-S-RBD, and are more likely to achieve high multiples of the cut-off levels. Vaccination after a history of COVID-19 results in generally higher antibody levels, supporting the use of a booster dose.
Article
Virology
Julien De Greef et al.
Summary: The kinetics of IgG antibodies after COVID-19 remain poorly understood, with levels decreasing significantly over time. Age, BMI, and immunosuppression appear to influence IgG kinetics, while short-term corticotherapy does not have a significant effect. Further research is needed to determine the determinants of long-term seroprotection against SARS-CoV-2.
JOURNAL OF MEDICAL VIROLOGY
(2021)
Article
Biochemistry & Molecular Biology
Joseph E. Ebinger et al.
Summary: Virus-specific antibody levels after a single dose of the BNT162b2 vaccine in individuals previously infected with SARS-CoV-2 are similar to levels after two doses of the vaccine in infection-naive individuals. Post-vaccine symptoms were more prominent for those with prior infection after the first dose, but symptomology was similar between groups after the second dose.
Review
Immunology
Ashok Kumar et al.
Summary: COVID-19 is a severe acute respiratory syndrome caused by SARS-CoV-2, a novel virus that has spread globally with higher infectivity and mortality compared to its earlier relatives. Understanding potential transmission routes and rapidly developed diagnostics are crucial in managing the disease.
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY
(2021)
Review
Immunology
Jaime Fergie et al.
Summary: This article summarizes the latest understanding of immunity to SARS-CoV-2 infection, including key antigens, importance in vaccine development, immediate immune response, coverage of emerging variants, contributions of preexisting immunity, and duration of immunity.
FRONTIERS IN IMMUNOLOGY
(2021)
Article
Infectious Diseases
David W. Eyre et al.
Summary: The study found that nearly all healthcare workers develop detectable anti-spike antibodies after receiving the Pfizer-BioNTech or Oxford-AstraZeneca vaccines. Those with prior infection and younger age were more likely to test seropositive after the first dose.
CLINICAL MICROBIOLOGY AND INFECTION
(2021)
Article
Virology
Aysen Bayram et al.
Summary: The study conducted antibody quantitation of the SARS-CoV-2 spike protein in healthcare workers in a university hospital in Turkey who were vaccinated with two doses of CoronaVac. It found a relatively high frequency of humoral immunity in HCWs aged 18-59 after vaccination. Antibody levels were significantly higher in individuals who had COVID-19 before vaccination and significantly lower in those with chronic diseases, suggesting the importance of monitoring antibody response for vaccine dosage decisions, especially in vulnerable groups.
JOURNAL OF MEDICAL VIROLOGY
(2021)
Article
Virology
Anton Barchuk et al.
Summary: This study evaluates antibody tests used in a serological study of SARS--CoV--2 in Saint Petersburg, Russia. Sensitivity and specificity varied among different antibody assays, with CMIA Abbott showing lower AUC. Less than 33% of participants with positive antibody test results had neutralizing antibodies in titers 1:80 and above.
JOURNAL OF MEDICAL VIROLOGY
(2021)
Article
Medicine, General & Internal
Yinon M. Bar-On et al.
Summary: After receiving a third dose of the BNT162b2 mRNA vaccine, Israeli residents aged 60 and above who had previously received two doses of the vaccine saw significantly lower rates of confirmed Covid-19 infection and severe illness compared to those who did not receive a booster shot, indicating the effectiveness of the booster dose in reducing infection and severe illness.
NEW ENGLAND JOURNAL OF MEDICINE
(2021)
Article
Medicine, General & Internal
Moriah Bergwerk et al.
Summary: Among fully vaccinated health care workers, breakthrough infections with SARS-CoV-2 were correlated with neutralizing antibody titers during the peri-infection period. Most breakthrough infections were mild or asymptomatic, although persistent symptoms did occur.
NEW ENGLAND JOURNAL OF MEDICINE
(2021)
Article
Microbiology
Jia Wei et al.
Summary: A longitudinal study on 45,965 adults in the UK revealed that older individuals, especially those aged >60 years, had lower antibody levels after a single dose of ChAdOx1 or BNT162b2 COVID-19 vaccines. Prioritizing vaccine allocation for those not previously infected and older individuals for the second dose is recommended based on the findings. Further data is needed to fully understand the relationship between quantitative antibody responses and vaccine-mediated protection.
NATURE MICROBIOLOGY
(2021)
Article
Medicine, General & Internal
Theocharis G. Konstantinidis et al.
Summary: This study aimed to evaluate the immunogenic effect of mRNA vaccine against SARS-CoV-2, with results showing a robust immune response in individuals previously infected with the virus compared to non-infected subjects. Interestingly, asymptomatic individuals after vaccination had lower levels of antibodies than those who experienced fever. High levels of anti-Spike COVID-19 antibodies were observed post-vaccination.
JOURNAL OF CLINICAL MEDICINE
(2021)
Article
Immunology
Emanuele Amodio et al.
Summary: This study assessed SARS-CoV-2 antibody concentrations in infected and vaccinated individuals, with almost all vaccinated subjects showing seropositivity and over 80% having IgG concentrations > 200 AU/mL. Vaccination was significantly associated with increased IgG concentrations, while older age, male sex, and days after immunization were associated with reduced IgG concentrations. Additional studies are needed to evaluate the role of age and days after immunization in antibody persistence and disease protection.
Article
Health Care Sciences & Services
Paul Naaber et al.
Summary: The study found that antibody levels declined at 12 weeks and 6 months after receiving two doses of BNT162b2 vaccine, with Spike antibody levels at 6 months being similar to those in individuals who received one dose or had recovered from COVID-19. Most individuals developed Spike-specific memory T cell responses, which were lower in those with higher T cell immunosenescence. Antibody response was negatively correlated with age and positively correlated with the total score of vaccination side effects.
LANCET REGIONAL HEALTH-EUROPE
(2021)
Article
Medicine, Research & Experimental
Luca Dalle Carbonare et al.
Summary: The study investigated the antibody response to SARS-CoV-2 mRNA vaccines in individuals with waning immunity due to previous infection, as well as IgA and IgM responses in individuals with prior infection or no prior exposure. It found that a single dose of vaccine in previously infected individuals triggered a stronger response than two doses in naïve individuals, inducing potent IgA responses unrelated to virus neutralization. Unusual IgM response patterns were also observed in nearly half of naïve individuals.
COMMUNICATIONS MEDICINE
(2021)
Article
Immunology
Frauke Muecksch et al.
Summary: Understanding the longitudinal trajectory of SARS-CoV-2 antibodies is crucial for diagnosis and immunity prediction. Different serological assays have varying suitability for surveillance and prediction of neutralization potency, with S-based assays better predicting neutralization levels over time.
JOURNAL OF INFECTIOUS DISEASES
(2021)
News Item
Medicine, General & Internal
Jennifer Abbasi
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
(2020)
Editorial Material
Public, Environmental & Occupational Health
Rok Civljak et al.
JOURNAL OF GLOBAL HEALTH
(2020)
Article
Biochemistry & Molecular Biology
Fatima Amanat et al.
Article
Multidisciplinary Sciences
Nina Le Bert et al.
